经皮腋动脉入路血管内碎石术辅助经股动脉经导管主动脉瓣植入术。
Intravascular Lithotripsy Enabled Transfemoral Transcatheter Aortic Valve Implantation via Percutaneous Axillary Access Approach.
机构信息
Division of Cardiovascular Diseases, Department of Medicine, RWJ-Barnabas Health Newark Beth Israel Medical Center, 201 Lyons Avenue, Newark, NJ 07112, United States of America.
Division of Cardiovascular Diseases, Department of Medicine, RWJ-Barnabas Health Newark Beth Israel Medical Center, 201 Lyons Avenue, Newark, NJ 07112, United States of America.
出版信息
Cardiovasc Revasc Med. 2021 Jul;28S:89-93. doi: 10.1016/j.carrev.2020.12.018. Epub 2020 Dec 17.
Transfemoral (TF) access for transcatheter aortic valve implantation (TAVI) is the most commonly used site, however its use may be limited by prohibitive peripheral arterial disease. Although a number of alternative access techniques have been well described, each has been shown to be associated with increased risks when compared to a TF approach. Recently, planned treatment of iliofemoral artery disease using intravascular lithotripsy (IVL) has emerged as a means of preserving TF access. Ipsilateral or contralateral femoral artery access has been routinely used to perform IVL but its use may be limited in certain conditions. Here we describe the novel technique of using percutaneous axillary artery access to perform IVL of iliofemoral artery to facilitate its use for large bore access. We present a 78-year-old high surgical risk female with severe aortic stenosis who was found to have a prior stent in the contralateral iliac artery protruding into the aorta which limited a traditional 'up and over' approach, and thus axillary artery access was used to perform IVL. This is the first case in literature to describe the use of percutaneous axillary access to perform IVL of the iliac and common femoral artery to facilitate TF TAVI. Based on our previous experience we feel this technique holds promise for a routine use when use of other access sites is limited.
股动脉(TF)入路是经导管主动脉瓣植入术(TAVI)最常用的入路,但由于外周动脉疾病的限制,其应用可能受到限制。虽然已经很好地描述了许多替代入路技术,但与 TF 方法相比,每种方法都显示出与增加的风险相关。最近,使用血管内碎石术(IVL)计划治疗髂股动脉疾病已成为保留 TF 入路的一种手段。同侧或对侧股动脉入路已常规用于进行 IVL,但在某些情况下其应用可能受到限制。在这里,我们描述了一种使用经皮腋动脉入路进行髂股动脉 IVL 的新技术,以促进其用于大口径入路。我们介绍了一位 78 岁的高危女性,患有严重的主动脉瓣狭窄,发现对侧髂动脉内有一个支架突入主动脉,限制了传统的“向上越过”方法,因此使用腋动脉入路进行 IVL。这是文献中首例描述使用经皮腋动脉入路进行髂内和股总动脉 IVL 以促进 TF TAVI 的病例。基于我们以前的经验,我们认为当其他入路受到限制时,这种技术有望常规使用。